Mobile World Congress 2012 is moving ate a break-neck speed and as we're bringing you all the latest news, scoops and device specifications from the showroom floor here in Barcelona, things are bound to get confusing.
To make your life easier and save you time navigating through the tons of content, we have made a table containing everything MWC 2012 as it's happening neatly organized for you.
MWC 2012 overview
ECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trial
Discussant - ECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trial
Discussant - EMPHASIS-HF. The effect of eplerenone versus placebo on cardiovascular mortality or heart failure hospitalization in subjects with NYHA class II chronic systolic heart failure: An analysis of the High-risk groups in the study population
RESET: One-year outcome of the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial
Discussant - RESET: One-year outcome of the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial
Comparison of three-year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel coronary artery disease: an observation from the CREDO-Kyoto PCI/CABG registry Cohort-2
Discussant - Comparison of three-year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel coronary artery disease: an observation from the CREDO-Kyoto PCI/CABG registry Cohort-2
A case of hypertrophic cardiomyopathy with left bundle branch block and severe heart failure.
What do the Guidelines say?
Tailored antithrombotic therapy in non ST-elevation-acute coronary syndrome.
What do the Guidelines say?
Stroke and bleeding risk assessment in a high risk atrial fibrillation patient who needs a coronary stent.
The 'truly low stroke risk' patient with atrial fibrillation: defining the population and what to do post-ablation.
Scope of the problem.
Cerebral artery disease.
Mesenteric and renal artery disease.
Lower extremity artery disease.
Multisite disease.
Closing remarks.
Is the optimisation of the atrioventricular and interventricular delays useful?
How to manage cardiac resynchronisation therapy in atrial fibrillation patients?
The use of cardiac resynchronisation therapy outside current guidelines.
Effectiveness in the RESPONSE trial.
Feasibility in the EUROACTION study.
Should we only focus on nurse-led programmes?
Do we know how to do it?
ASE/EAE recommendations about echo assessment of left ventricular mechanics.
EAE position paper on pocket size imaging devices.
EAE recommendations about the use of echo in Emergency Department.
Natural history.
When to intervene.
Rationale for surgery.
Rationale for stenting.
SMART-AV: The role of electrical delay (QLV) to predict left ventricular reverse remodeling with cardiac resynchronization therapy
Discussant - SMART-AV: The role of electrical delay (QLV) to predict left ventricular reverse remodeling with cardiac resynchronization therapy
PACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trial
Discussant - PACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trial
Discussant - IRIS: Why does the implantable cardioverter-defibrillator not improve mortality early after myocardial infarction - Insights from the Immediate Risk Stratification Improves Survival (IRIS) trial
SHIFT: Relationship between heart rate and health related quality of life. Results from SHIFT
Discussant - SHIFT: Relationship between heart rate and health related quality of life. Results from SHIFT
SHIFT: Selective heart rate reduction with Ivabradine improves left ventricular remodeling and function: insights from the SHIFT-Echocardiography sub-study
Discussant - SHIFT: Selective heart rate reduction with Ivabradine improves left ventricular remodeling and function: insights from the SHIFT-Echocardiography sub-study
Discussant - STICH: Influence of mitral valve repair on survival in the surgical treatment for Ischemic heart failure trial
'Old Therapies': how was myocardial infarction management in 1970?
Future therapies for myocardial infarction in 2050: cells, genetics and pharmacogenomics.
Future interventional therapies and new devices for myocardial infarction in 2050.
Difficult echocardiography in an adult patient previously unknown to have congenital heart disease.
Difficult echocardiography in an adult patient with repaired congenital heart disease.
Role of 2D and 3D echo in aortic stenosis- Tips and tricks.
Is there a role for computed tomography/myocardial magnetic resonnance imaging in aortic stenosis ?
Integration of coronary anatomy, function, perfusion and metabolism.
Myocardial characterisation using cardiovascular magnetic resonnance.
Optical coherence tomography in acute coronary syndrome.
Intravascular ultrasound to optimize percutaneous intervention results.
New therapy for atherosclerosis targeting folate receptor-beta expressing macrophages
Effector memory T cells are related to the atherosclerotic process in humans and murine models
Essential role of CD4 T cells in Angiotensin II-induced atherosclerosis and vulnerable atherosclerotic plaque development
MicroRNA expression in peripheral blood monocytes in different stages of atherosclerosis development in humans
Sodium channelopathies in the developing heart - a key to understanding adult arrhythmogenesis.
Linking Pitx2 insufficiency to atrial fibrillation.
Brugada syndrome: a developmental perspective.
Calcium channelopathies: current appraisal and future hopes.
Predicting survival in chronic heart failure: a risk score based on 47886 patients from 31 studies
Prognostic value of baseline NT-proBNP and its interactions with irbesartan treatment in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure. Results from two large randomized clinical trials
State of the Art - Probing prognosis in heart failure
A rare variant in MYH6 confers high risk of sick sinus syndrome
A dominant negative missense mutation in MOG1 induces trafficking defect of cardiac sodium channel and is associated with Brugada syndrome ECG pattern
State of the Art - Featured research on genetic aspects of cardiac arrhythmias
Introduction.
Diagnosis and risk stratification.
Antiplatelet and anticoagulation treatment.
Invasive management.
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension.
Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial
Confirmation of sustainability of hemodynamic response to baroreflex activation therapy in patients with resistant hypertension
Effects of percutaneous renal denervation in patients with resistant hypertension on ambulatory blood pressure measurement and dipping
State of the Art - Can we cure resistant hypertension?
Smoking and obesity/overweight: relations to all-cause mortality and major cardiovascular in a population-based cohort of men and women
Smokeless tobacco (snus) and mortality after myocardial infarction
Reduced incidence of ST-elevation myocardial infarction in the first two years after introduction of a public smoking ban in canton ticino, switzerland
Smoking relapse and mortality after acute coronary syndromes
State of the Art - Tobacco use, no smoke without fire.
Persistent smoking in high-risk patients - the reality in clinical practice and how to improve.
Strategies for smoking cessation - evidence from trials.
Right ventricular adaptation to pressure load in mice is improved after blockade of calcineurin activation
Baseline difference in transcriptional patterns between PAH patients and normal volunteers
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
State of the Art - Pathobiological changes in pulmonary arterial hypertension
Echocardiography.
Multidetector computed tomography.
Invasive diagnostic procedures.
Transforming growth factor is linked to abnormal collagen turnover leading to impaired myocardial deformation in untreated hypertensives
Global two-dimensional strain as a novel parameter of myocardial fibrosis, and the assessment of risk for major cardiac events in patients with hypertrophic cardiomyopathy
Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy: a multi-modality study
Epicardial fat volume on non-contrast computed tomography is associated with high-risk coronary artery plaque features
Platelet reactivity on clopidogrel therapy and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent pharmacodynamic analysis of the GRAVITAS trial
Impact of the cytochrome P450 2C19*3 polymorphism on platelet reactivity and adverse clinical events in patients with acute myocardial infarction
The Italian Elderly ACS study: Early aggressive versus initially conservative strategy in elderly patients with non-ST- elevation acute coronary syndrome: the Italian Elderly ACS randomised trial (ClinicalTrials.gov ID: NCT00510185)
Is clopidogrel discontinuation following acute coronary syndrome hospitalisation associated with a higher risk of death and myocardial infarction?
The PACIFIC registry: one-year follow-up data of a 2-Year study in patients initially hospitalised with ACS
The European CRT survey: 1 year follow-up results
FRANCE II: French registry aortic national corevalve and Edwards registry II
Considerably lower risk of stent thrombosis and restenosis in "new generation" drug-eluting stents: a report from the nation wide complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Longterm clinical outcomes and duration of dual antiplatelet therapy after drug-eluting stent implantation: landmark analyses from CREDO-KYOTO Cohort-2 registry
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-elevation myocardial infarction: eleven years of experience from the western denmark heart registry.
Improved two-year outcomes of STEMI patients treated with drug-eluting compared with bare-metal stents. Experiences from the randomized BASKET-PROVE trial
State of the Art - Old challenges in interventional cardiology: new answers from very large multicenter studies
Download link:
Extabit
http://extabit.com/file/27a2goymo4ao5/ESCWebccasts29Aug2011_Softarchive.net.part1.rar
http://extabit.com/file/27a2goymo4ath/ESCWebccasts29Aug2011_Softarchive.net.part2.rar
http://extabit.com/file/27a2goymo4at1/ESCWebccasts29Aug2011_Softarchive.net.part3.rar
http://extabit.com/file/27a2goympd2mt/ESCWebccasts29Aug2011_Softarchive.net.part4.rar
http://extabit.com/file/27a2goymo419x/ESCWebccasts29Aug2011_Softarchive.net.part5.rar
http://extabit.com/file/27a2goymo47kl/ESCWebccasts29Aug2011_Softarchive.net.part6.rar
Shareflare
http://shareflare.net/download/06641.03742ad3092357c15c68f6e30a1f/ESCWebccasts29Aug2011_Softarchive.net.part1.rar.html
http://shareflare.net/download/50266.5797ebf85630179bc0fa9c593b8c/ESCWebccasts29Aug2011_Softarchive.net.part2.rar.html
http://shareflare.net/download/40298.41120eca4b1980778189ad219c49/ESCWebccasts29Aug2011_Softarchive.net.part3.rar.html
http://shareflare.net/download/52182.5e5aecee4d1c94566bda2b6fae74/ESCWebccasts29Aug2011_Softarchive.net.part4.rar.html
http://shareflare.net/download/47580.4298ff97b69874e4e2efd7e02c7e/ESCWebccasts29Aug2011_Softarchive.net.part5.rar.html
http://shareflare.net/download/68792.6d270d8f590d9b67db1fb5346694/ESCWebccasts29Aug2011_Softarchive.net.part6.rar.html
Letitbit
http://letitbit.net/download/55941.518b8b596fe8f3f2ae206b35a4ad/ESCWebccasts29Aug2011_Softarchive.net.part1.rar.html
http://letitbit.net/download/44939.40e92993a7ccb880150680ef30c5/ESCWebccasts29Aug2011_Softarchive.net.part2.rar.html
http://letitbit.net/download/92237.9ac02292e974223d2569ab3221f7/ESCWebccasts29Aug2011_Softarchive.net.part3.rar.html
http://letitbit.net/download/83612.8982b0274a3ed7cce828e813b2b2/ESCWebccasts29Aug2011_Softarchive.net.part4.rar.html
http://letitbit.net/download/62508.6c5de1142343594a1b775e7481ce/ESCWebccasts29Aug2011_Softarchive.net.part5.rar.html
http://letitbit.net/download/32942.3ea6760a7cf8f498163e6abcde60/ESCWebccasts29Aug2011_Softarchive.net.part6.rar.html
Uloaded.to
http://ul.to/file/dis3eock/ESCWebccasts29Aug2011_Softarchive.net.part1.rar
http://ul.to/file/zgpdogao/ESCWebccasts29Aug2011_Softarchive.net.part2.rar
http://ul.to/file/jlnqq61t/ESCWebccasts29Aug2011_Softarchive.net.part3.rar
http://ul.to/file/dw1tp591/ESCWebccasts29Aug2011_Softarchive.net.part4.rar
http://ul.to/file/n65ibi6o/ESCWebccasts29Aug2011_Softarchive.net.part5.rar
http://ul.to/file/8ily1y3k/ESCWebccasts29Aug2011_Softarchive.net.part6.rar
Rapidshare
The Following Users Say Thank You to congtu89 For This Useful Post: European Society of Cardiology Congress 2011 Video Training
The House and Senate plan to vote Friday on the $143 billion package, which features two of President Barack Obama's chief ingredients for strengthening the economy.
Passage seems virtually certain in the House and likely in the Senate, though its fate there is less assured. Some Democratic senators are defecting because of cuts in civil servants' pensions and other issues. Many Republicans are opposed because the bill will add $89 billion to federal deficits over the next decade.
With November elections looming, though, most lawmakers seem ready to end the long-running fight.
The House and Senate plan to vote Friday on the $143 billion package, which features two of President Barack Obama's chief ingredients for strengthening the economy.
Passage seems virtually certain in the House and likely in the Senate, though its fate there is less assured. Some Democratic senators are defecting because of cuts in civil servants' pensions and other issues. Many Republicans are opposed because the bill will add $89 billion to federal deficits over the next decade.
With November elections looming, though, most lawmakers seem ready to end the long-running fight.
"I believe this country was founded on a simple idea: that every person deserves to be treated fairly, by each other and by their government, but that's not happening in America anymore," Kennedy, a Democrat, said ahead of an announcement scheduled for Thursday.
He said he would work hard to earn every vote and if elected would "bring that fight for fairness to the U.S. Congress."
Kennedy, the son of former U.S. Rep. Joseph Kennedy II and a grandson of the late Robert F. Kennedy, recently moved from Cambridge to Brookline, part of the state's newly redrawn 4th Congressional District.
The family has deep ties to the Boston suburb. Brookline is the site of the birthplace of Kennedy's great-uncle, the late President John F. Kennedy.
Kennedy announced last month he was forming an exploratory committee to look at a possible run for the seat. He isn't the only candidate in the race, though.
Republican Sean Bielat, who lost to Frank, a Democrat, in 2010, also has jumped into the contest. He made his announcement official in January.
"I think we started something last time," Bielat, a former U.S. Marine who lives in Norfolk, said at the time. "I think we made some big gains, but we didn't get the job done."
Republican Elizabeth Childs, of Brookline, a former state mental health commissioner under former Gov. Mitt Romney, has also announced her intention to run for the GOP nomination.
Kennedy planned to release a video announcement on his campaign website Thursday morning before heading out on a campaign swing through the district.
Kennedy is scheduled to start the day greeting commuters at the Newton Center Green Line MBTA Station before making stops in Milford, Attleboro, Taunton and Westport.
The Kennedy family has seen its influence in Washington fade in recent years as its younger generations have largely shunned public office.
The death of Massachusetts' U.S. Sen. Edward Kennedy, Joseph Kennedy's great-uncle, in 2009 left a void for the family. The retirement of his son, Rhode Island's U.S. Rep. Patrick Kennedy last year marked the first time in 63 years that a Kennedy wasn't serving in elected office in Washington.
Joseph Kennedy III is a graduate of Stanford University, where he studied management science and engineering and was co-captain of the lacrosse team, and of Harvard Law School, where he served as technical editor of the Harvard Human Rights Journal. He served in the Peace Corps in the Dominican Republic from 2004 to 2006.
Kennedy has not held elective office, but he and his twin brother, Matt Kennedy, served as co-chairmen for Edward Kennedy's final re-election campaign in 2006.
Joseph Kennedy III has served as a prosecutor for the Cape and Islands district attorney's office and more recently as an assistant district attorney in the Middlesex district attorney's office, a job from which he resigned last month.
Last month, he also announced he's engaged to be married to Lauren Anne Birchfield, a fellow Harvard Law School graduate.
Other Democratic candidates in the district, which stretches from the Boston suburbs to Fall River, include Paul Heroux, an Attleboro businessman; Herb Robinson, asoftware engineer from Newton; and Jack Porter, a Newton sociologist and real estate consultant.
The 71-year-old Frank announced in November that he would not seek re-election after serving for more than three decades in Congress. In part, the prospect of running in a newly redrawn district with 325,000 new constituents prompted the decision.
Massachusetts has had to redraw its congressional map from 10 districts to nine districts after it lost a seat as a result of the last federal census tally.
